Life Science Company News

Reset
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

BetterLife Advances BETR-001 IND-enabling Studies

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  BetterLife Pharma Inc.

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Annexon, Inc. | Annexin Pharmaceuticals AB (publ)

AltruBio to Participate in Upcoming May 2024 Medical Conferences

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  AltruBio Inc.

Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer and Chief Business Officer

Read more ››
By: GlobeNewswire - 01 May 2024

PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  PharmaTher Holdings Ltd.

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Editas Medicine, Inc.

Touro University Nevada College of Osteopathic Medicine Teaches Living Anatomy and Physiology with Vave Health Pocket Ultrasound

Read more ››
By: GlobeNewswire - 01 May 2024

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Ardelyx, Inc

Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Cocrystal Pharma, Inc.

Pliant Therapeutics to Participate in Upcoming Investor Events

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Pliant Therapeutics, Inc.

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  CytomX Therapeutics, Inc.

Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia

Read more ››
By: GlobeNewswire - 01 May 2024

VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  VYNE Therapeutics Inc.

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Avadel Pharmaceuticals plc

The Canadian Dermatology Association urges Canadians to protect themselves from skin cancer this summer

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Canadian Dermatology Association

Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Creyon Bio, Inc.

Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Supernus Pharmaceuticals, Inc.

Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity

Read more ››
By: GlobeNewswire - 01 May 2024

Goodness Growth Provides CREAM & Fire Updates

Read more ››
By: GlobeNewswire - 01 May 2024

Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Akari Therapeutics Plc
Results 141 - 160 out of 500 displayed.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »